ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Uncovering the Q-marker and potential mechanisms of Qishan Formula for lung cancer based on multi-technology

Sui, Yutong*; Yang, Yanqun; Zhang, Jing; Wang, Ziwei; Geng, Xue; Jiang, Jiakang南方医科大学; 1
Journal of Liquid Chromatography and Related Technologies2023-9-15DOI: 10.1080/10826076.2023.2216765
10阅读
引用收藏
分享

摘要

Qishan Formula (QSF) is mainly used to treat lung cancer and its side effects of radiotherapy and chemotherapy. Although the clinical efficacy of QSF has been recognized, its mechanism of action and active ingredients are still unclear. This study aims to explore the potential Q-Marker of QSF and reveal its anti-lung cancer mechanism. Firstly, the fingerprints of 10 batches of QSF were established, and the potential Q-markers were screened by chemometrics, then network pharmacology and molecular docking methods were used to explore its anti-lung cancer mechanism. Finally, the potential Q-markers were quantitatively by UPLC-QDA. The results showed that 48 common peaks were identified by the established fingerprint, and calycosin, ginsenoside Rg1, atractylenolide III, atractylenolide I and ginsenoside Rb1 were screened as potential Q-Markers of QSF by chemometrics. Network pharmacology and molecular docking found that the potential Q-Markers may regulate various signaling pathways through targets such as FOS, IL6, EGFR, ESR1, MAPK1, and MAPK3, and play a therapeutic role in lung cancer. Besides, the established UPLC-QDA can also perform quality control for Q-Markers of QSF. This study can provide academic ideas and lay a foundation for the comprehensive quality control and mechanism research of QSF and other compound preparation.

学科与关键词

关键词
Chemometricsfingerprintintegrative analysisQishan Formulaquality marker
相关
加载中…
  • Determining the mechanism of action of the Qishan formula against lung adenocarcinoma by integration of network pharmacology, molecular docking, and proteomics
    Geng, Xue; Chi, Wencheng; Lin, Xiaoyue; Niu, Zeji; Jiang, Qinghui; Sui, Yutong; Jiang, Jiakang*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2023, 102(13).
  • Intervention effect of Qi-Yu-San-Long Decoction on Lewis lung carcinoma in C57BL/6 mice: Insights from UPLC–QTOF/MS-based metabolic profiling
    Huan Wu; Yang Chen; Qinglin Li; Yating Gao; Xingxing Zhang; Jiabing Tong; Zhiqiang Zhang; Jian Hu; Danyang Wang; Shijie Zeng; Zegeng LiJournal of Chromatography B, 2018, s 1102–1103: 23-33.
  • A Mechanism Exploration for the Yi-Fei-San-Jie Formula against Non-Small-Cell Lung Cancer Based on UPLC-MS/MS, Network Pharmacology, and In Silico Verification
    Hu, Leihao; He, Canfeng; Mo, Aier; Zhan, Xingkai; Yang, Caizhi; Guo, Wei; Sun, Lingling; Su, Weiwei*; Lin, Lizhu*Evidence-based Complementary and Alternative Medicine, 2023, 2023: 3436814.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Liquid Chromatography and Related Technologies
发表日期
2023-09-15
卷期
第 46 卷, 第 6-10 期
页码
118-126
DOI
10.1080/10826076.2023.2216765
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82104585]; Graduate Innovation Foundation of Heilongjiang University of Chinese Medicine [yjscx2017002]; Administration of Traditional Chinese Medicine of Guangdong Province [20211273]

作者

  • S

    Sui, Yutong (通讯) (第一作者)

    southern med univ

  • Y

    Yang, Yanqun

    southern med univ

查看全部 6 位作者收起作者
  • Z

    Zhang, Jing

    southern med univ

  • W

    Wang, Ziwei

    southern med univ

  • G

    Geng, Xue

    heilongjiang univ chinese med

  • J

    Jiang, Jiakang

    heilongjiang univ chinese med · 1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417